![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Ind-swift Laboratories Limited Chandigarh In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Clopidogrel hydrogen sulfate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2013-215 - Rev 00
This Chemical Type CEP, issued on March 31, 2020, remains in force until February 21, 2024, ensuring its reliability within the pharmaceutical industry.
Substance Number 2531 associated with this CEP further emphasizes